| Net earnings | 298M |
| Depreciation and amortization | 189M |
| Stock compensation expense | 112M |
| Gain on sale of investments, net | |
| Debt extinguishment costs | |
| Gain on sale of UHP | |
| Deferred income taxes | |
| Premium and related receivables | -906M |
| Other current assets | |
| Other assets | |
| Medical claims liabilities | 15M |
| Unearned revenue | 301M |
| Accounts payable and accrued expenses | 99M |
| Other operating activities | 91M |
| Net cash provided by (used in) operating activities | 255M |
| Capital expenditures | -211M |
| Capital expenditures of Centene Center LLC | |
| Purchases of investments | -1.53B |
| Proceeds from asset sales | |
| Sales and maturities of investments | 955M |
| Investments in acquisitions, net of cash acquired | |
| Net cash used in investing activities | -1.63B |
| Proceeds from exercise of stock options | |
| Proceeds from borrowings | 6.96B |
| Proceeds from stock offering | |
| Payment of long-term debt | -4.26B |
| Contributions from (distributions to) noncontrolling interest | |
| Excess tax benefits from stock compensation | |
| Common stock repurchases | -29M |
| Debt issue costs | -59M |
| Net cash provided by financing activities | 2.6B |
| Net increase (decrease) in cash and cash equivalents | 1.22B |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |
| Interest paid | 113M |
| Income taxes paid | 394M |
| Contribution from noncontrolling interest | |
| Capital expenditures | |